INS and type 2 diabetes mellitus: The UK Hypoglycaemia Study Group (2007) found no difference in T2DM patients treated with sulfonylureas (SUs) or insulin for less than two years in both the proportion experiencing severe hypoglycaemia and the proportion experiencing mild symptomatic hypoglycaemia over a 9–12-month period [1].